首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Notch1 Receptor Regulates AKT Protein Activation Loop (Thr308) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells
【2h】

Notch1 Receptor Regulates AKT Protein Activation Loop (Thr308) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells

机译:Notch1受体通过调节磷酸酶和张力蛋白同源物(PTEN)-null T细胞急性淋巴细胞白血病细胞中的PP2A磷酸酶调节AKT蛋白活化环(Thr308)的去磷酸化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Notch1 activating mutations occur in more than 50% of T-cell acute lymphoblastic leukemia (T-ALL) cases and increase expression of Notch1 target genes, some of which activate AKT. HES1 transcriptionally silences phosphatase and tensin homolog (PTEN), resulting in AKT activation, which is reversed by Notch1 inhibition with γ-secretase inhibitors (GSIs). Mutational loss of PTEN is frequent in T-ALL and promotes resistance to GSIs due to AKT activation. GSI treatments increased AKT-Thr308 phosphorylation and signaling in PTEN-deficient, GSI-resistant T-ALL cell lines (Jurkat, CCRF-CEM, and MOLT3), suggesting that Notch1 represses AKT independent of its PTEN transcriptional effects. AKT-Thr308 phosphorylation and downstream signaling were also increased by knocking down Notch1 in Jurkat (N1KD) cells. This was blocked by treatment with the AKT inhibitor perifosine. The PI3K inhibitor wortmannin and the protein phosphatase type 2A (PP2A) inhibitor okadaic acid both impacted AKT-Thr308 phosphorylation to a greater extent in nontargeted control than N1KD cells, suggesting decreased dephosphorylation of AKT-Thr308 by PP2A in the latter. Phosphorylations of AMP-activated protein kinaseα (AMPKα)-Thr172 and p70S6K-Thr389, both PP2A substrates, were also increased in both N1KD and GSI-treated cells and responded to okadaic acid treatment. A transcriptional regulatory mechanism was implied because ectopic expression of dominant-negative mastermind-like protein 1 increased and wild-type HES1 decreased phosphorylation of these PP2A targets. This was independent of changes in PP2A subunit levels or in vitro PP2A activity, but was accompanied by decreased association of PP2A with AKT in N1KD cells. These results suggest that Notch1 can regulate PP2A dephosphorylation of critical cellular regulators including AKT, AMPKα, and p70S6K.
机译:Notch1激活突变发生在50%以上的T细胞急性淋巴细胞白血病(T-ALL)病例中,并增加Notch1靶基因的表达,其中一些激活AKT。 HES1转录使磷酸酶和张力蛋白同源物(PTEN)沉默,从而导致AKT活化,而AKT活化可被γ-分泌酶抑制剂(GSI)抑制Notch1逆转。 PTEN的突变丢失在T-ALL中很常见,并由于AKT激活而增强了对GSI的抗性。 GSI处理增加了PTEN缺陷型,GSI耐药性T-ALL细胞系(Jurkat,CCRF-CEM和MOLT3)中AKT-Thr 308 的磷酸化和信号转导,这表明Notch1可以独立于其PTEN抑制AKT。转录作用。敲除Jurkat(N1KD)细胞中的Notch1也可以增加AKT-Thr 308 的磷酸化和下游信号传导。通过用AKT抑制剂periposine治疗可以阻止这种情况。与非N1KD细胞相比,PI3K抑制剂渥曼青霉素和2A蛋白磷酸酶(PP2A)抑制剂冈田酸对AKT-Thr 308 磷酸化的影响均大于N1KD细胞,提示AKT-Thr 308 。在N1KD和GSI处理的细胞中,两种PP2A底物AMP活化的蛋白激酶α(AMPKα)-Thr 172 和p70S6K-Thr 389 的磷酸化也均增加了冈田酸治疗。隐含转录调控机制是因为显性阴性主干样蛋白1的异位表达增加,而野生型HES1减少了这些PP2A靶的磷酸化。这与PP2A亚基水平或体外PP2A活性的变化无关,但在N1KD细胞中伴随着PP2A与AKT缔合的降低。这些结果表明,Notch1可以调节关键细胞调节剂(包括AKT,AMPKα和p70S6K)的PP2A去磷酸化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号